poisar

Stock

Labcorp Holdings Inc. LH

$296.66+1.91%

Overview

LH market data

Price History

LH price chart

Valuation & Profitability

Twelve Data
P/E (TTM)
25.65
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
$10.46
Diluted earnings per share over the trailing twelve months.
Beta
0.87
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
99.0%
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$244.52 – $298.46
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $24.1K · P/B 2.41 · P/S 1.71.

Company news

8 captured
Global Cancer Biomarkers Market to Reach $37.8 Billion by 2035 as Precision Oncology Adoption Accelerates - Trends and Forecasts Till 2035Globenewswire Inc · Jul 22, 2026, 11:00 AM
B of A Securities Maintains Buy on Labcorp Holdings, Raises Price Target to $320Benzinga · Jul 13, 2026, 5:44 PM
Baird Maintains Outperform on Labcorp Holdings, Raises Price Target to $338Benzinga · Jul 13, 2026, 5:42 PM
8-K filing — LABCORP HOLDINGS INC. (LH)SEC EDGAR · Jul 10, 2026, 11:31 AM
Labcorp Announces Nationwide Availability Of ColoSense, Its RNA-Based, At-Home Colorectal Cancer Screening TestBenzinga · Jun 22, 2026, 11:25 AM
Labcorp Enters Collaboration The Alliance For Clinical Trials In Oncology To Advance A National, Multicenter Clinical Trial For Patients Newly Diagnosed With Colorectal CancerBenzinga · May 29, 2026, 11:05 AM
Labcorp Announces Availability Of Expanded DPYD Genotyping Test To Help Identify Cancer Patients At Increased Risk For Severe Fluoropyrimidine Chemotherapy Side EffectsBenzinga · May 28, 2026, 11:20 AM
Labcorp Launches MyLabcorp AI App, Integrating Lab Results And Guideline‑Based Health ContentBenzinga · May 20, 2026, 11:20 AM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock